Bimat Information
Bimat is a prescription drug, available for use as Drops. Primarily, it is used for the treatment of Glaucoma.
The optimal dosage of Bimat is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Bimat include Eye itching, Eye irritation, Eye Burning. Apart from the aforementioned side effects, Bimat can also lead to other problems, which have been listed below. Such side effects of Bimat normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Bimat's effect is Unknown during pregnancy and Unknown for lactating mothers. Further, the section on Bimat related warnings talks about Bimat's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Bimat contraindications section.
Besides this, Bimat may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Bimat is safe while driving, and is is addictive in nature.
Bimat Benefits & Uses
Bimat is used to treat the following -
Other Benefits
Bimat Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Bimat Side Effects
Based on research, the following side effects have been observed when Bimat is used -
Common
- Eye itching
- Eye irritation
- Eye Burning
Bimat Related Warnings
-
Is the use of Bimat safe for pregnant women?
No research has been done to ascertain the safety of Bimat in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Unknown -
Is the use of Bimat safe during breastfeeding?
Information about safety of Bimat for women who are breastfeeding is not available since scientific research on this is yet to be done.
Unknown -
What is the effect of Bimat on the Kidneys?
Bimat is completely safe for kidneys.
Safe -
What is the effect of Bimat on the Liver?
Using Bimat does not have any harmful effects on the liver.
Safe -
What is the effect of Bimat on the Heart?
You can take Bimat without any fear of damage to the heart.
Safe
Severe Interaction of Bimat with Other Drugs
Bimat should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Bimat Contraindications
If you are suffering from any of the following diseases, you should not take Bimat unless your doctor advises you to do so -
- Uveitis
- Corneal Abrasion
- Kidney Disease
- Liver Disease
Frequently asked Questions about Bimat
-
Is this Bimat habit forming or addictive?
No, there is no any evidence that Bimat is addictive.
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Bimat since it will not make you feel sleepy.
Safe -
Is it safe?
Yes, Bimat does not show any kind of adverse effect.
Safe -
Is it able to treat mental disorders?
Bimat is unable to treat or cure mental disorders.
No
Bimat Interactions with Food and Alcohol
-
Interaction between Food and Bimat
Taking Bimat with food does not cause any problems.
Safe -
Interaction between Alcohol and Bimat
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Bimat.
Unknown
See all substitutes for Bimat
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 227-228
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lumigan® (bimatoprost)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Latisse® (bimatoprost)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bimatoprost Sandoz® (bimatoprost)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lumigan® Pf (bimatoprost)
